David Klonoff to Infusions, Subcutaneous
This is a "connection" page, showing publications David Klonoff has written about Infusions, Subcutaneous.
Connection Strength
0.243
-
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obes Metab. 2019 04; 21(4):961-967.
Score: 0.196
-
Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. J Diabetes Sci Technol. 2018 07; 12(4):880-889.
Score: 0.047